“Northern hemisphere countries have so far ordered more than one billion doses of swine flu vaccine, the World Health Organisation said Tuesday, sparking warnings over shortages,” Agence France-Presse reports.
The WHO’s flu chief Keiji Fukuda on Saturday called upon wealthy nations and vaccine manufacturers to donate H1N1 (swine) flu vaccines to developing countries, the Associated Press reports.
The H1N1 (swine) flu is blamed for 557 deaths in Brazil, “making it the country with the highest number of fatalities in the world from the disease,” according to the country’s health ministry, Agence France-Presse reports.
“The White House, months before flu season, will roll out the big guns Thursday for a swine flu preparedness summit, underscoring the importance the Obama administration is placing on the pandemic,” CNN reports.
“Saying the new H1N1 [swine flu] virus is ‘unstoppable’, the WHO gave drug makers a full go-ahead to manufacture vaccines against the pandemic influenza strain on Monday and said healthcare workers should be the first to get one,” Reuters reports (Fox, 7/14). This, as “Britain, Brazil, Colombia, Mexico, the Philippines…
HHS Secretary Kathleen Sebelius said Sunday the U.S. has agreed to put an addition $1 billion towards ingredients for the production of a vaccine that offers protection against the H1N1 (swine flu) virus, Reuters reports.
“In a move that caught many public health experts by surprise, the WHO quietly announced Thursday that it would stop tracking swine flu cases and deaths around the world,” the New York Times reports.
The following articles look at how countries are combating H1N1 (swine flu): NPR’s Morning Edition examines the “complicated” task ahead to administer two vaccines â€“ one that offers protection against the seasonal flu, the other protecting against the H1N1 (swine flu) virus â€“ to the public this fall (Knox, 7/20).…
“Global health officials are scrambling to try to prevent the spread of the H1N1 swine flu virus, with U.S. officials moving Thursday with a recommendation that the Food and Drug Administration approve or license a [new H1N1] vaccine,” without waiting on the results from “clinical trials to test its safety and efficacy,” Wall Street Journal reports (Dooren/Winning, 7/24).
The race to develop a H1N1 (swine flu) vaccine before the fall flu season ramped up Wednesday, after Australia launched the first human trials of the H1N1 vaccine and scientists from the U.S., China and Britain announced plans for human trials of an H1N1 vaccine in the coming weeks, AFP/France24.com reports.